Phlomoides umbrosa
Phlomoides umbrosa · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Phlomoides umbrosa is a botanical species recognized for its significant therapeutic potential in managing bone and joint health. Research indicates that extracts derived from its roots and rhizomes, particularly the HT042 formulation, are effective in addressing conditions such as osteoarthritis and various rheumatic diseases. The plant's chemical profile is rich in bioactive compounds, including 7-Epiphlomiol, 8-acetyl-shanzhiside methyl ester, Alyssonoside, and Decaffeoylverbascoside. Scientists often utilize specific preparations like ethylacetate-fractions to isolate these medicinal properties for clinical application. Consequently, this plant serves as a vital natural resource in the ongoing study of systemic inflammatory and degenerative bone diseases.
- Synonyms
- Phlomoides Umbrosa Var. Ovalifolia · Phlomoides Umbrosa Var. Latibracteata · 13 more
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Root · Rhizome
Classification
Common Names
Phlomoides umbrosa is a versatile botanical species known by several distinct regional names. In Japan, this plant is affectionately referred to by its common name, ヒカゲキセワタ. Moving to China, it is widely recognized under the name 糙苏. It also holds a significant place in Korean culture, where it is called 속단. Understanding these various linguistic identities helps enthusiasts identify the plant across different geographic landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Phlomoides umbrosa is a botanical species known to exist under several different taxonomic names. Within botanical literature, it is frequently identified by the synonym Phlomis stenocalyx. The plant is also closely associated with the name Phlomis umbrosa, which serves as a common alternative designation. Further variations include specific forms and varieties such as Phlomis umbrosa f. albiflora and Phlomis umbrosa f. villosa. Additionally, the taxon is recognized under the name Phlomis umbrosa var. australis, illustrating the complex nomenclatural history of this species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Phlomoides umbrosa belongs to the vast kingdom Plantae, showcasing the incredible diversity of the botanical world. Within this kingdom, it is classified under the class Equisetopsida. Its specific lineage continues through the order Lamiales, which links it to many other significant flowering plants. This species is a member of the Lamiaceae family, a group often characterized by aromatic properties. Ultimately, it is defined by its membership in the genus Phlomoides.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Phlomoides |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Phlomoides umbrosa is a plant species primarily found throughout the Asia-Temperate region. Its natural distribution spans several diverse territories within China, including the North-Central, South-Central, and Southeast regions. Beyond these central areas, the species also makes a significant presence in the northern reaches of Inner Mongolia. Furthermore, its habitat extends into the Manchuria region, illustrating a wide geographical range. This widespread occurrence highlights the plant's ability to thrive across various ecological zones in East Asia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Phlomoides umbrosa is a self-supporting plant that maintains its own structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Phlomoides umbrosa is a traditional medicinal plant that has been studied extensively for its complex chemical profile. Research into its rhizomes has successfully isolated several significant compounds, including 7-Epiphlomiol and 8-acetyl-shanzhiside methyl ester. Additionally, the plant is known to contain Alyssonoside and Decaffeoylverbascoside, which contribute to its diverse phytochemical makeup. The presence of iridoid compounds further highlights its potential value in pharmacological applications. These various constituents support the plant's long-standing use in treating bone and rheumatic diseases.
Conditions
Phlomoides umbrosa treats TRAP-positive cell formations by inhibiting the differentiation of osteoclasts in a dose-dependent manner. This medicinal plant also treats bone diseases and osteoarthritis through the regulation of protein-encoding genes and the PI3K/AKT pathway. Furthermore, Phlomoides umbrosa treats cyclophosphamide-induced immunosuppression when included in herbal mixtures like HT042 to enhance both innate and adaptive immunity. Its ethylacetate-fraction is specifically noted to treat leiomyomal cell proliferation by significantly inhibiting the growth of these cells. Together, these properties highlight the diverse therapeutic potential of the plant in addressing bone, immune, and reproductive health issues.
Preparations
Phlomoides umbrosa is prepared as roots and rhizomes to isolate various chemical constituents, including iridoid aglycones and glycosides. The plant is also prepared as extracts that have been studied for their therapeutic potential in treating osteoarthritis through the regulation of the PI3K/AKT pathway. Additionally, Phlomoides umbrosa is prepared as an ethylacetate-fraction which has demonstrated the ability to significantly inhibit the proliferation of leiomyomal cells. Furthermore, this plant is prepared as part of the Astragalus Extract Mixture HT042 to promote growth and enhance immune function.
Parts used
Phlomoides umbrosa is a traditional medicinal plant found primarily in northern China. Scientific research has highlighted the importance of its specific anatomical structures, particularly the root and the rhizome. In the Hubei province, the roots are traditionally utilized by the Tujia nationality to treat various rheumatic diseases. Recent studies have focused on isolating chemical constituents from the rhizome using advanced chromatography techniques. These investigations have successfully identified several unique compounds, including both known iridoids and newly discovered chemical structures.